Our survival analysis revealed that MCL patients with low OGT (cutoff: below Q3) together with high BCL2L1 and low BAX have shorter survival than those patients with high OGT: the hazard ratio increased by approximately three-fold. The gene discussed is BCL2L1; the disease is mantle cell lymphoma.